Hepatitis B virus (HBV) variants with precore mutation(s) resulting in the absence of HBeAg production have been associated with the occurrence of fulminant hepatitis in Japan, Israel, and southern Europe, where the prevalence of this HBV strain appears common. In areas such as United States, where HBV infection is not endemic, the role of this mutant virus in fulminant hepatitis is unknown. We developed an amplification refractory mutation detection system to detect specifically the presence of the G to A mutation at nucleotide position 1898, which is the most frequently observed mutation resulting in a precore stop codon. In addition, this method provided a quantitative measurement of the relative ratio of one strain to the other. Using this system, we tested HBV strains for the presence of the stop codon mutation in sera from 40 cases of fulminant hepatitis B occurring in the United States. Serum HBV DNAs from 28 patients were analyzed successfully. A mixture of wild-type and mutant strains in various ratios were observed in 15 patients, wild type exclusively in 11, and mutant exclusively in 2. Four of these patients had undergone liver transplantation for HBV-associated cirrhosis and developed fulminant HBV-associated hepatitis after transplantation. Pre-and posttransplant serum samples from one patient were analyzed: a mixture of wild-type and mutant HBV strains was detected in both samples. Our study demonstrated that both wild-type and mutant HBV strains are associated with fulminant hepatitis, and that in some patients in the United States, factors other than precore mutations contribute to the development of fulminant hepatitis. (J. Clin. Invest. 1994. 93:550-555.)
Introduction
Hepatitis B virus (HBV) variants with precore mutation(s) resulting in the absence of HBeAg production have been associated with the occurrence of fulminant hepatitis in Japan, Israel, and southern Europe, where the prevalence of this HBV strain appears common. In areas such as United States, where HBV infection is not endemic, the role of this mutant virus in fulminant hepatitis is unknown. We developed an amplification refractory mutation detection system to detect specifically the presence of the G to A mutation at nucleotide position 1898, which is the most frequently observed mutation resulting in a precore stop codon. In addition, this method provided a quantitative measurement of the relative ratio of one strain to the other. Using this system, we tested HBV strains for the presence of the stop codon mutation in sera from 40 cases of fulminant hepatitis B occurring in the United States. Serum HBV DNAs from 28 patients were analyzed successfully. A mixture of wild-type and mutant strains in various ratios were observed in 15 patients, wild type exclusively in 11, and mutant exclusively in 2. Four of these patients had undergone liver transplantation for HBV-associated cirrhosis and developed fulminant HBV-associated hepatitis after transplantation. Pre-and posttransplant serum samples from one patient were analyzed: a mixture of wild-type and mutant HBV strains was detected in both samples. Our study demonstrated that both wild-type and mutant HBV strains are associated with fulminant hepatitis, and that in some patients in the United States, factors other than precore mutations contribute to the development of fulminant hepatitis. (J. Clin. Invest. 1994. 93:550-555.) Key words: hepatitis B virus * fulminant hepatitis,, precore mutation * polymerase chain reaction * hepatitis C virus Infection with hepatitis B virus (HBV)' is associated with a broad spectrum of liver injury, ranging from acute self-limited infection to fulminant hepatitis, chronic hepatitis with or without progression to cirrhosis and liver failure, as well as to an asymptomatic chronic carrier state. Evidence has been accumulating to indicate that HBV mutants unable to synthesize HBeAg may influence the course ofinfection and clinical manifestations of disease (1) (2) (3) . Many mutations inactivating the precore open reading frame necessary for the synthesis of HBeAg have been described (4, 5) . These mutations have been observed to arise de novo in patients chronically infected with wild-type HBV (6) , and acute infection with such mutants appears to be associated with fulminant hepatitis (7-9).
We have previously described the association of an HBV variant containing two precore mutations with an epidemic of fulminant hepatitis B in Israel (7) . The HBV strain responsible for this epidemic contained two G to A mutations in the precore open reading frame (nucleotides [nt] 1898 and 1901), one of them resulting in a stop codon. Other laboratories have also reported similar findings in patients with sporadic fulminant hepatitis B in Japan (8, 9) . Using an amplification refractory mutation detection system (ARMDS) (10) Amplification refractory mutation detection system. Serum DNA was isolated as described previously (11) . Extracted DNA was subjected to ARMDS for specific detection of the G to A mutation at nt 1898 (10) . This system is depicted schematically in Fig. 1 . Two HBV primers (primers 1 and 2) spanning nt 1605-2432 ofthe HBV genome were used in the first PCR amplification. An aliquot of reaction product was then amplified further in a second reaction with primers 3 and 4, which are contained within the region spanned by the first two primers. Primer 3 had either a G (primer 3W) or A (primer 3M) at the 3' end, corresponding to nt position 1898. Therefore, primers 3W and 3M were referred to as the "detection primers," one specific for the wild-type G and the other for the mutant A sequence, respectively. In addition, a mutation of T to G was introduced at the third position from the 3' end ofthe detection primer to further enhance the specificity of the amplification reaction (10) . The primer sequences were: primer 1, 5' GTTGCATGGAGACCACCGTGAAC 3' (sense, nt 1605-1627); primer 2,5' GCTTCTGCGACGCGGCGATTGAGA 3' (antisense, nt 2432-2410); primer 4, 5' CGAGGGAGTT CTTCTT-CTAG 3' (antisense, nt 2394-2375). The sequences for primers 3W and 3M are shown in Fig. 1 
Results
Using oligonucleotide-directed mutagenesis, we have previously generated three mutant HBV genomes with precore mutations: one with the G to A mutation at nt 1901 (GA), the second with the G to A mutation at nt 1898 (AG), and the third with both ofthe G to A mutations (AA) ( 1 3). To demonstrate the utility of ARMDS, we subjected these three HBV mutant DNAs together with the wild-type HBV DNA to the ARMDS analysis. The results are shown in Fig. 2 . By either ethidium bromide staining (A) or Southern Blot hybridization (B), the reactions were specific with respect to the primers used. Using the wild-type primer (primer 3W), we detected amplification signals only in reactions with wild-type and GA mutant DNA (lanes 3, 4, 7, and 8), whereas the mutant primer (primer 3M) only amplified AG and AA mutant DNAs (lanes 5, 6, 9, and 10).
To assess the potential ofthe ARMDS method in providing a quantitative measurement of the ratio of the precore mutant to wild-type virus, we mixed wild-type and mutant (AG) HBV DNAs in various proportions and subjected the mixtures to PCR with either primer 3W or 3M and primer 4. The resulting PCR products were analyzed by Southern blot hybridization, and the signals generated by the PCR reaction were subjected to densitometric measurements (Fig. 3) . The resulting OD readings from the actual autoradiogram (A) were plotted against either the wild-type or mutant DNA concentrations (B). The results indicated that the signals generated with either of the primers were fairly linear over a two-log concentration range with respect to the ratios of wild-type vs mutant DNA concentrations. Therefore, using these two primers, we were able to obtain a semiquantitative measurement of the level of the precore mutant with the G to A mutation at nt 1898.
After establishing the sensitivity and specificity of the ARMDS method, we proceeded to analyze some of the serum samples we had characterized previously (Fig. 4) . By DNA sequencing, we have previously described the association ofthe G to A mutation at nt 1898 with an epidemic of fulminant hepatitis B in Israel (7). Serum HBV DNA from five of the Table I (patients 1-6 and 24) were analyzed as well, and the results are shown in Figure 4 (lanes 9-15) . In a parallel experiment, we isolated and sequenced four to five independent PCR clones of the precore/core region from each of the patients.
The results of DNA sequencing demonstrated that patients [1] [2] [3] [4] [5] [6] had the wild-type sequence, and that patient 7 had the mutant sequence at nt position 1898 in all clones. The results of the ARMDS analysis were comparable to the sequencing data, except in patients 2 and 4 (lanes 11 and 13, respectively), whose clones contained small amounts of the mutant strains. The
proportions of mutant to wild-type DNA in either of the two samples were < 1: 100, as evidenced by extrapolating the ratio of OD readings on the graph in Fig. 3 B. Because only four to five clones from each sample were sequenced, we were not surprised that only the wild-type sequence was detected. Third, the level of HBV viremia is often low during the symptomatic phase of fulminant hepatitis ( 14) , and our sensitivity of detection using PCR is consistent with the findings of other reports ( 15, 16) . Nevertheless, the clinical and serological features of those 12 patients whose serum samples we could not detect HBV DNA were not different from those of patients detailed in Table I 
Discussion
Studies in other laboratories as well as our own have linked the occurrence of fulminant hepatitis to infection by HBV mutants unable to synthesize HBeAg (7) (8) (9) . In addition, other reports have suggested that this HBV mutant can lead to to a more severe chronic hepatitis and resistance to interferon therapy ( 17) . Some ofthese associations, however, could be coincidental, reflecting merely the prevalence of this mutant form of HBV infecting those populations under study ( 18, 19) . In this study, we first established that the amplification refractory mutation detection system is a rapid, sensitive, and specific method to detect the G to A mutation at nt position 1898. It also provides a quantitative measurement for the relative ratio of one strain to the other in a sample. The ability to assess quantitatively the level of this specific mutation will be useful in analyzing the fluctuation of circulating amounts of each strain in response to antiviral therapy. In addition, this methodology can be applied easily to the detection of other mutations in the viral genome. Similarly, sequence-specific oligonucleotides have been used to determine semiquantitatively the relative prevalence of each viral strain in a mixture of viral strains ( 19). Our technique, however, has the advantage of revealing the presence ofa small percentage (< 5%) ofa viral strain in the mixture.
Using this ARMDS method, we detected both wild-type and mutant HBV strains in patients with sporadic fulminant hepatitis in the United States. In addition, no appreciable difference in the clinical course of disease was observed between those patients with and without mutant infection. The argument can be made that since we were detecting only the G to A mutation at nt 1898, we could have missed other mutations affecting the precore open reading frame and resulting in the absence of HBeAg production. Other such mutations have been described (5, 6) ; however, we have independently cloned and sequenced the precore region in eight cases of our study cohort and noted wild-type sequences in seven ofthem. Therefore, we conclude that the wild-type HBV strain, at least with respect to HBeAg synthesis, is often detected in patients with fulminant hepatitis B. Our observation is also supported by other studies (20, 21 ) . Furthermore, both wild-type and mutant HBV strains could be detected in patients with acute, selflimited hepatitis B. However, the majority ofpatients harbored predominantly wild-type strain and no patients had exclusively mutant form. Since serum samples from many of our cases were collected and stored in the distant past, it was not possible for us to obtain well-matched controls for our study cases in each geographic area. Nonetheless, our study demonstrated unambiguously that both wild-type and mutant HBV strains are associated with fulminant hepatitis, and that other host or viral factors are important in the development of fulminant hepatitis in the United States. However, in this study, we cannot exclude a possible contribution of the HBV precore mutant to the development of more severe liver disease.
Four ofthe patients (patients 20-23) underwent orthotopic liver transplantation for HBV-associated cirrhosis, and fulminant hepatitis developed after transplantation. In these patients, reinfection by the same HBV strain(s) probably resulted in the rapid course of hepatic failure. A mixture of HBV strains was detected in their serum samples after transplantation. One patient, patient 20 The presence of both HBV and HCV markers in two of our patients probably reflects the well-known epidemiological association of both viral infections (22, 23) . Since there are no serologic tests yet available to distinguish between acute and chronic HCV infection, whether acute HCV infection contributed to the development of fulminant hepatitis in these patients remains to be established.
The pathophysiologic and clinical significance ofthe G to A precore mutation is still largely unknown at present. Conceivably, this mutation may alter the regulation of HBV transcription and replication by providing a more thermodynamically stable packaging signal for the encapsidation of HBV pregenomic RNA (24, 25) . Data from our laboratory and others ( 13, 26) , however, suggest that these mutations do not affect viral protein synthesis, transcription, or replication in transfected human hepatoma cells. Woodchuck hepatitis virus variants containing this precore mutation appeared to replicate normally in woodchucks (27) . Instead, the absence of HBeAg production as an immune target may confer a biological advantage to the virus as it encounters the immune response in infected host; indeed this may be the major reason for the emergence of these HBV precore mutants. Within the precore open reading frame, there are several possible codons that can be mutated to a stop codon resulting in the abrogation of HBeAg synthesis (26) . Why the mutation occurs predominantly in the codon involving nt 1898 is not apparent at present. This can be explained potentially by preferential mutagenesis targeting to this nucleotide during HBV replication. Since the precore region also contains the Direct Repeat-1 and the encapsidation signal, mutations resulting in other potential stop codons may exert deleterious effect on the replication of HBV; if they are lethal mutations, with no evolutionary advantage, they would not become clinically detectable. A similar G to A mutation has been observed in the viral genome during replication of hepatitis D virus both in tissue culture and in infected hosts (28) . It is tempting to speculate about the existence of a putative "virulence factor" associated with certain strains of HBV; such a viral property could potentially affect the clinical course of infection and possibly constitute the molecular basis for the diverse manifestations of HBV-induced liver disease.
